Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900022993Phase 4Completed
Phase 4, open-label trial of dexmedetomidine, lidocaine, esketamine and remifentanil in gallbladder disease (2 arms), sponsored by Hefei First People's Hospital. Primary endpoints: Requirement for rescue analgesics and Postoperative pain score. Started Jun 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900022993.